Cytosine arabinoside plus cisplatin and other drugs as chemotherapy for gliomas - PubMed (original) (raw)
. 1987 Jun;14(2 Suppl 1):110-5.
- PMID: 3589685
Cytosine arabinoside plus cisplatin and other drugs as chemotherapy for gliomas
D J Stewart et al. Semin Oncol. 1987 Jun.
Abstract
Twenty-five evaluable patients with gliomas were treated with a combination of cytosine arabinoside plus cisplatin administered intravenously (IV). Ten of the 25 patients (40%) responded, including three of 13 patients (23%) with prior cranial radiation, and seven of 12 patients (58%) without prior cranial radiation. In a second study, intramuscular (IM) and oral caffeine were added to IV cytosine arabinoside plus cisplatin. Caffeine-induced seizures prevented escalation of the dose of caffeine to a level that would have been anticipated to potentiate the cytotoxicity of the cytosine arabinoside plus cisplatin. Twelve of 25 treated patients (48%) responded. Most of the patients had not received prior cranial radiation. In a third study, IV cytosine arabinoside was administered in combination with intracarotid and IV cisplatin, plus BCNU and tenoposide (VM-26). This study is continuing to accrue patients. Myelosuppression has been pronounced, but has generally been rapidly reversible. It is too early to comment on efficacy of this combination. Our results to date permit us to conclude that the combination of cytosine arabinoside plus cisplatin is capable of inducing regression of gliomas in some patients. We feel that further studies are warranted.
Similar articles
- Feasibility study of intraarterial vs intravenous cisplatin, BCNU, and teniposide combined with systemic cisplatin, teniposide, cytosine arabinoside, glycerol and mannitol in the treatment of primary and metastatic brain tumors.
Stewart DJ, Grahovac Z, Hugenholtz H, DaSilva V, Richard MT, Benoit B, Belanger G, Russell N. Stewart DJ, et al. J Neurooncol. 1993 Jul;17(1):71-9. doi: 10.1007/BF01054276. J Neurooncol. 1993. PMID: 8120574 Clinical Trial. - Intracarotid chemotherapy with a combination of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), cis-diaminedichloroplatinum (cisplatin), and 4'-O-demethyl-1-O-(4,6-O-2-thenylidene-beta-D-glucopyranosyl) epipodophyllotoxin (VM-26) in the treatment of primary and metastatic brain tumors.
Stewart DJ, Grahovac Z, Benoit B, Addison D, Richard MT, Dennery J, Hugenholtz H, Russell N, Peterson E, Maroun JA, et al. Stewart DJ, et al. Neurosurgery. 1984 Dec;15(6):828-33. doi: 10.1227/00006123-198412000-00010. Neurosurgery. 1984. PMID: 6392925 Clinical Trial. - Combined intraarterial and systemic chemotherapy for intracerebral tumors.
Stewart DJ, Grahovac Z, Hugenholtz H, Russell N, Richard M, Benoit B. Stewart DJ, et al. Neurosurgery. 1987 Aug;21(2):207-14. doi: 10.1227/00006123-198708000-00013. Neurosurgery. 1987. PMID: 2443873 - The role of chemotherapy in the treatment of gliomas in adults.
Stewart DJ. Stewart DJ. Cancer Treat Rev. 1989 Sep;16(3):129-60. doi: 10.1016/0305-7372(89)90007-8. Cancer Treat Rev. 1989. PMID: 2695239 Review. - Chemotherapy of malignant gliomas: studies of the BTCG.
Shapiro WR. Shapiro WR. Rev Neurol (Paris). 1992;148(6-7):428-34. Rev Neurol (Paris). 1992. PMID: 1448662 Review.
Cited by
- Accelerated radiotherapy with concomitant ACNU/Ara-C for the treatment of malignant glioma.
Anders K, Grabenbauer GG, Schuchardt U, Fahlbusch R, Fietkau R, Sauer R, Krauseneck P. Anders K, et al. J Neurooncol. 2000 May;48(1):63-73. doi: 10.1023/a:1006498525605. J Neurooncol. 2000. PMID: 11026699 Clinical Trial. - Methylxanthines: Potential Therapeutic Agents for Glioblastoma.
Pérez-Pérez D, Reyes-Vidal I, Chávez-Cortez EG, Sotelo J, Magaña-Maldonado R. Pérez-Pérez D, et al. Pharmaceuticals (Basel). 2019 Sep 7;12(3):130. doi: 10.3390/ph12030130. Pharmaceuticals (Basel). 2019. PMID: 31500285 Free PMC article. - G2 checkpoint abrogation and checkpoint kinase-1 targeting in the treatment of cancer.
Bucher N, Britten CD. Bucher N, et al. Br J Cancer. 2008 Feb 12;98(3):523-8. doi: 10.1038/sj.bjc.6604208. Epub 2008 Jan 29. Br J Cancer. 2008. PMID: 18231106 Free PMC article. Review. - Plasma and cerebrospinal fluid pharmacokinetics of cytosine arabinoside in dogs.
Scott-Moncrieff JC, Chan TC, Samuels ML, Cook JR, Coppoc GL, DeNicola DB, Richardson RC. Scott-Moncrieff JC, et al. Cancer Chemother Pharmacol. 1991;29(1):13-8. doi: 10.1007/BF00686329. Cancer Chemother Pharmacol. 1991. PMID: 1742843 - Direct delivery of platinum-based antineoplastics to the central nervous system: a toxicity and ultrastructural study.
Olivi A, Gilbert M, Duncan KL, Corden B, Lenartz D, Brem H. Olivi A, et al. Cancer Chemother Pharmacol. 1993;31(6):449-54. doi: 10.1007/BF00685034. Cancer Chemother Pharmacol. 1993. PMID: 8453683
MeSH terms
Substances
LinkOut - more resources
Medical